Evidence map›Paper›PMID 31509942›Full record

ReviewMedicina (Kaunas, Lithuania)2019

Combined Pulmonary Fibrosis and Emphysema: Pulmonary Function Testing and a Pathophysiology Perspective.

Diana E Amariei, Neal Dodia, Janaki Deepak, Stella E Hines, Jeffrey R Galvin, Sergei P Atamas, Nevins W Todd

Open access · goldAbstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. The Dual Threat Combined Pulmonary Fibrosis and Emphysema (CPFE): Two Cases.International journal of chronic obstructive pulmonary disease · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Deep Learning Assessment of Progression of Emphysema and Fibrotic Interstitial Lung Abnormality.American journal of respiratory and critical care medicine · 2023
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Diana E AmarieiDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Neal DodiaDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Janaki DeepakDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Stella E HinesDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Jeffrey R GalvinDepartment of Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Sergei P AtamasDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Nevins W ToddDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA. ntodd@som.umaryland.edu.
University of Maryland, Baltimore · USVeterans Health Administration · US

Funding

The Mechanisms of Profibrotic Sensitization by IL33R01HL126897 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI LUZINA, IRINA G. · 2015 to 2018
$1.4M
NIH HHS R01HL126897U.S. Department of Veterans Affairs VA Merit Award I01BX002499
6 · The paper itself

Abstract

Combined pulmonary fibrosis and emphysema (CPFE) has been increasingly recognized over the past 10-15 years as a clinical entity characterized by rather severe imaging and gas exchange abnormalities, but often only mild impairment in spirometric and lung volume indices. In this review, we explore the gas exchange and mechanical pathophysiologic abnormalities of pulmonary emphysema, pulmonary fibrosis, and combined emphysema and fibrosis with the goal of understanding how individual pathophysiologic observations in emphysema and fibrosis alone may impact clinical observations on pulmonary function testing (PFT) patterns in patients with CPFE. Lung elastance and lung compliance in patients with CPFE are likely intermediate between those of patients with emphysema and fibrosis alone, suggesting a counter-balancing effect of each individual process. The outcome of combined emphysema and fibrosis results in higher lung volumes overall on PFTs compared to patients with pulmonary fibrosis alone, and the forced expiratory volume in one second (FEV

Indexed as

Respiratory Function TestsHumansPulmonary EmphysemaPulmonary Fibrosisdiffusing capacity for carbon monoxideelastic recoilemphysemalung compliancelung volumespulmonary fibrosisspirometry

Identifiers

PMID31509942
PMCPMC6780454
OpenAlexW2972656970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.